and lightly restrained male Wistar rats previously implanted with a catheter in the jugular vein. Escherichia coli LPS was injected intravenously in a dose of 0, 0.1, 1, 10, 100, or 1,000 yg/kg. Colonic temperature (T,) was measured with a thermocouple.
Changes in nociception were assessed by tail flick latency (TFL) to a noxious heat stimulus. Motor activity was evaluated using an observation-based activity score (AS). The two lowest doses were apyrogenic. The next dose induced a monophasic fever with a maximal T, rise of 0.9 ? 0.2"C at 108 2 11 min post-LPS. The next two higher doses caused biphasic fevers with the first and second peaks of 0.7 t 0.1 and 1.4 t_ O.l"C (10 ug/kg) and 0.7 t 0.1 and 1.4 ? 0.2"C (100 pg/kg) occurring at 60 t 6 and 165 ? 17 min and at 45 t 3 and 141 t 6 min, respectively. The highest dose of LPS resulted in a T, fall (nadir, -0.6 ? O.l"C at 83 t-6 min). Two different sickness patterns were exhibited. The first (high T,, low TFL, and high AS) occurred during the monophasic fever and the first (early) phase of the biphasic fevers, and it was termed the early phase syndrome. The second pattern (high or low T,, high TFL, and low AS) developed during the second (late) phase of the biphasic fevers and LPS-hypothermia (endotoxin shock), and it was termed the late phase syndrome.
Occurring at different stages of the systemic inflammatory response and developing through different coping patterns [fight/flight (energy expenditure) vs. depression/withdrawal (energy conservation)], the two syndromes represent two different types of adaptation to infection and have different biological significance. Viewing sickness as a dynamic entity is justified clinically. Such a dynamic approach to the problem resolves several contradictions in the current concept of sickness. thermoregulation; behavior; pain; adaptation; systemic inflammation; rats AFTER THE FUNDAMENTAL REVIEW by Hart(6), establishing the adaptive value of the sickness-associated behavior, several attempts (e.g., Refs. 10, 42, 43) have been made to characterize nonspecific behavioral and physiological responses to infectious challenge and to identify their mechanisms. The revealed sickness syndrome is thought to include fever as its central symptom and be primarily mediated by pyrogenic cytokines: interleukins (ILs)-1 and -6, tumor necrosis factors (TNFs), and interferons (IFNs). Along with fever, several other symptoms (depression, sleepiness, anorexia, hyperalgesia, etc.) are now recognized as signs of sickness. In his review, Hart (6) mentioned that some symptoms of sickness change as a disease progresses from its onset to outcome. This issue, however, has not been further developed. We hypothesize that, as a disease evolves, the strategy of fighting it changes and that, reflecting this change, the sickness syndrome undergoes two distinct stages characterized by different physiological and behavioral responses.
The present study addresses this hypothesis by investigating the biphasic febrile response of rats to intravenous administration of a bacterial lipopolysaccharide (LPS, endotoxin) . This model is widely used in research of both fever and stress. The two phases of biphasic fever appear to differ in several respects. The first (early) phase is characterized by precise body temperature (Tb) control (although at a new, elevated level). The precision, however, drastically decreases during the second (late) phase (34, 37, 39) because of the development of threshold dissociation (i.e., separation between the threshold Tb for activation of cold-defense mechanisms and that for triggering heat-defense responses) and possibly a decrease in the effector sensitivity to Tb. The first phase of fever is accompanied by a rise in blood pressure, although normotension (30) or even slight hypotension (unpublished observations) occurs during the second phase. It has been further suggested that the early phase is coupled with wakefulness, whereas the late phase is associated with sleep (28). Furthermore, according to the majority of authors (for references, see 26), the two phases are differently mediated: the first is likely to involve prostaglandins of the E series (PGE), whereas the mediators of the second phase, yet unidentified, are thought to be different from PGE. A different physiological pattern and different biochemical mediation of the early vs. late febrile phase suggest that the two phases are associated with different sickness symptoms. The primary aim of the present study was to reveal the changes in Tb, pain perception, and motor activity during LPSinduced biphasic fever and thus to investigate whether R245 the early and late phases are characterized by distinct sickness patterns.
Although the most typical thermal response to an intravenous bolus injection of LPS is biphasic fever, lower (just above subpyrogenic) doses of LPS cause monophasic Tb rises, and very high doses induce hypothermia and endotoxin shock (11, 27 and experimental sessions, the rats had no access to water or food. Each animal was experimented on only once. After an experiment, the rats were observed for 24 h and then killed with a lethal intraperitoneal injection of pentobarbital sodium.
Surgical Preparation
One-half hour before surgery, each rat received a prophylactic intramuscular injection of gentamicin sulfate (50 mg/kg). The animal was then anesthetized with an intraperitoneal injection of ketamine-xylazine (75 and 5 mg/kg, respectively), and a l-cm longitudinal incision was made on the ventral surface of the neck, 1 cm to the right of the trachea. The muscles were retracted, and the right jugular vein was exposed and freed from its surrounding connective tissue. A silicone catheter (ID 0.5 mm, OD 0.9 mm) containing heparinized (100 U/ml) pyrogen-free saline (PFS) was passed into the vena cava superior through the jugular vein. The 15-cm-long free end of the catheter was tunneled subcutaneously, exteriorized in the interscapular area, flushed with heparinized PFS, knotted, rolled into a coil, and secured with tape. The wound on the neck was sutured.
The following day, the catheter was flushed and its conductance verified. The animal was used in an experiment 2 days after surgery.
Experimental Protocols
To assess thermal, nociceptive, and motor responses to LPS, colonic temperature (T,) was monitored, pain perception was determined in the repeated tail flick (TF) test, and motor activity was evaluated by observing the animal. The tail skin temperature (T& was also recorded to exclude its potential confounding effect on the results of the TF test (1). Each rat was instrumented with colonic and tail skin thermocouples, placed in its restrainer, and transferred to the experimental chamber. After a l-h adaptation to the experimental conditions, measurements were started. The parameters under investigation were monitored from 0.5 h before until 5 h after the intravenous injection of LPS or PFS (control). To obviate possible effects of circadian rhythms, all experiments were started around 1O:OO A.M. To create optimal conditions for responding to LPS with a fever, T, in the experimental chamber was maintained at 29-31°C i.e., at the upper limit or slightly above the rat's thermoneutrality (verified by tail skin vasodilation).
Drugs
The Escherichia coli Olll:B4 LPS (List Biological Laboratories, Campbell, CA; lot no. LPS-25E) was used in this study. It was suspended in PFS and stored at 4°C. On the basis of preliminary experiments and our recent study (27), the following doses of LPS were administered (in ug/kg): 0 (PFS only; control), 0.1 (subpyrogenic dose), 1 (monophasic feverinducing dose), 10 and 100 (biphasic fever-inducing doses), and 1,000 (shock-inducing dose). Injections were made in a volume of 0.1 ml/kg and followed by flushing of the intravenous catheter with 0.1 ml PFS.
Physiological
Measurements and Data Analysis
Temperatures. T,, Tsk, and T, were measured with copper constantan thermocouples.
A colonic thermocouple was inserted 8.5 cm beyond the anus. A skin thermocouple was attached to the ventral surface of the tail, on the border of its proximal and middle thirds. The reference junction of each thermocouple was kept at 0°C. The signal from a thermocouple was fed to an amplifier (model Fll6/2 or B7-34; KINAP, St. Petersburg, Russia) and sent through an analogto-digital converter (SETU-10; MIS, Moscow, Russia) to an Apple IIe computer.
TF response. For TF testing, a noxious radiant-heat stimulus was delivered by focusing the beam from a 250-W quartzhalogen light bulb on the dorsal surface of the tail (-75 mm from the base). The heated area was -4 mm in diameter (as determined in a model experiment by measuring the coagulation zone in egg white after 30-s heating).
The TF response was evaluated using its latency (TFL; the time from the onset of the stimulation to tail withdrawal). The stimulus intensity was adjusted so that under normal conditions TFL was -7 s. This value of TFL corresponded to -5OOC Tsk in the focus of the light beam (measured in separate experiments).
To prevent burns, the cut-off time was set at 20 s; if the TF did not occur within this time, stimulation was terminated, and the TFL was assigned a value of 20 s.
Motor actiuity. An animal's motor activity was evaluated by observing the rat over 5-min periods. For each period, an activity score (AS) was assigned according to the following scale: 0, no movements within the period of observation; 1, sporadic movement; 2, substantial motor activity occupying less than one-half of the observation period; and 3, marked activity during more than one-half of the period; one additional point was added if the movements were accompanied by vocalization.
The scored movements included rotation around the longitudinal axis of the body, grooming, rearing, attempts at turning around the sagittal axis of the body, and movements of the head, tail, and paws. Because the spontaneous activity of the habituated and restrained rats was quite low, AS could change only in one direction (i.e., increase). The scoring was done by an observer who was "blind" to the administered dose of LPS. In addition to the scored behaviors, we also noted shivering, chattering, eye closure, relaxed elongation of the body, and hunched posture; these behavioral reactions were not accounted for in AS.
Data processing and analysis. For each recorded variable (T,, Tsk, TFL, and AS), the null hypothesis was that the responses to all six doses of LPS are the same. For T,, Tsk, and R246 
RESULTS
The dependence of the thermal response to LPS on the dose is shown in Fig. 1 . The analysis of variance [F( 125,850) = 28.0; P < 10m6] easily rejected the hypothesis that the thermal responses to various doses of LPS were all alike. At a dose of 1 ug/kg, LPS caused a monophasic fever with the peak of 0.9 ? 0.2OC reached at 108 or: 11 min postinjection. Administration of two higher doses resulted in biphasic fevers with the first and second peaks of 0.7 of: 0.1 and 1.4 t O.l°C (10 ug/kg) and 0.7 ? 0.1 and 1.4 t 0.2OC (100 pg/kg) occurring at 60 t 6 and 165 t 17 min and at 45 t 3 and 141 t 6 min, respectively. In response to the highest dose of LPS (1,000 ug/kg), all animals similarly exhibited the initial T, fall (nadir, -0.6 t O.l"C at 83 t 6 min) and a slow T, restoration thereafter.
However, the individual responses diverged at -150 min postinjection: in some animals, T, started falling again; in others, it was maintained for the next few hours at a relatively constant level; and yet, in still others, T, continued to gradually increase. This diversification resulted in the mean AT, showing no dynamics for the last 3 h of the experiment and stabilizing at about -0.3OC. In contrast to lower doses of LPS, administration of the 1,000~ug/kg dose resulted in some mortality: three out of eleven (27%) animals receiving this dose died -3 h postinjection (results of these three experiments were 2.0 r excluded from the data). Both the subpyrogenic dose of LPS (0.1 ug/kg; for the sake of figure clarity, not shown in Fig. 1 ) and PFS induced no changes in T,.
The thermal responses to LPS followed responses of the tail skin blood vessels (Fig. 2) . Each rise of T, (during both mono-and biphasic fevers) was preceded by a decrease in Tsk, indicating vasoconstriction, and the fall of T, at the onset of LPS-induced shock was preceded by a Tsk rise, indicating vasodilation. The subpyrogenic dose of LPS (not shown) and PFS induced no changes in T,. The analysis of variance for Tsk [F( 125,850) = 10.2; P < 10e6] allowed the rejection of the null hypothesis.
The dependence of the nociceptive response to LPS on dose is shown in Fig. 3 . The analysis of variance for TFL [F(40,271) = 8.0; 1 missing data point; P < 10m6] rejected the null hypothesis. Animals that received the subpyrogenic dose of LPS (not demonstrated) or PFS exhibited no changes in their pain perception throughout the experiment and consistently responded to the noxious heat stimulus with a TFL of -7 s. During the monophasic fever, TFL decreased to 5.3 t 0.6 s at 72 t 7 min post-LPS. The biphasic fever caused by 10 pg/kg LPS was accompanied by a TFL decrease as well (4.2 t 0.3 s at 42 t 7 min). This decrease was, however, followed by an increase in TFL (15.2 t 1.0 s) at 183 t 23 min post-LPS. At 100 pg/kg, LPS similarly induced a decrease in TFL (5.0 _ + 0 3 s at 48 2 7 min) during the . first febrile phase and an increase (15.2 t 1.8 s at 246 rt 36 min) during the second phase. As the LPS dose increased to 1,000 ug/kg, the nociceptive response transformed into a monophasic rise in TFL, with the peak of 18.2 ? 1.1 s occurring at 158 ? 26 min postinjection. Note that, at late stages of their response to LPS, some animals did not respond to the tail heating with the TF before the cut-off time (i.e., within 20 s): one rat at 210 min after the injection of 10 ug/kg, another at 300 min after the injection of 100 pg/kg, and five others at 90 (2), 210 (2), and 300 min (1) 1,000 ug/kg were similar to those during the response to PFS or the subpyrogenic dose of LPS, those at late stages of the monophasic fever, and those before the injection of LPS in higher doses. However, at late stages, responses to the three highest doses were characterized by a different behavior. In addition to elongating their bodies (also expressed during monophasic fever, simultaneously with defervescence), the animals closed their eyes, quit chattering, and often rested their heads on the floor of the restrainer.
DISCUSSION Physiological Responses to LPS
Thermal response. In this study, rats responded to a low, just above subpyrogenic, dose of LPS (1 ug/kg) with a monophasic fever, to two higher doses (10 and 100 ug/kg) with biphasic fevers, and to the highest dose (1,000 yg/kg) with hypothermia. The latter response, associated with a 27% mortality, represented endotoxin shock. Indeed, a rapid fall in the blood pressure has been demonstrated (27) to accompany hypothermia induced even by a smaller dose of LPS (500 ug/kg). The dose dependence of the rats' thermal response to LPS is in agreement with previous studies (11, 27) .
Biphasic fever, the typical response to moderate LPS doses, is the major focus of the present paper. The first phase of biphasic fever is characterized by equal upward shifts in the threshold Tb for activation of the heat-defense mechanisms and threshold Tb for induction of the cold-defense responses (38, 39); as a result, Tb is precisely regulated during the first phase at a new, elevated level. The second phase of biphasic LPS fever is also often characterized by an elevated level of Tb (such was the case in the present study), but not always. Under "unfavorable" conditions, such as insufficient nutrition (31, 35), physical restraint (17), or low T, (35), the second febrile rise in Tb readily changes to hypothermia. Moreover, as the stress associated with fever becomes more severe (because of either unfavorable conditions or a greater pyrogen dose), the hypothermia occurs earlier and becomes the predominant change in Tb, as seen in endotoxin shock. The mechanism of this hypothermia is the development of threshold dissociation (38, 39). Within a relatively wide range (between the threshold for activation of heat-defense mechanisms and that for activation of cold-defense mechanisms), Tb becomes the result of passive heat exchange between the body and the environment. The threshold dissociation constitutes, therefore, "the same central thermoregulatory process that leads to biphasic fever in some instances [e.g., when T, is high] and results in hypothermia in other cases [e.g., when T, is low]" (35). The fact that thermoregulatory manifestations of the response to a pyrogen, especially at its late stages, can be represented by either fever or hypothermia is in agreement with the clinical definition of the systemic inflammatory response syndrome: both fever and hypothermia are listed as key symptoms (19).
Nociception. In the present study, administration of LPS decreased TFL at the onset of the monophasic fever and during the early phase of biphasic fevers, but increased TFL during the late phase of biphasic fevers and endotoxin shock. It should be noted that TFL strongly depends on T,,; an increase in Tsk per se results in a decrease in TFL and vice versa (1). Therefore, SICKNESS SYNDROME:
A DYNAMIC ENTITY R249 evaluation of nociception by TFL could be a problem if the pyrogen dose is high, the likelihood of observing the changes in Tsk are not taken into account. The hypoalgesia increases. Similar to LPS and cytokines, a changes in TFL observed in the present study after LPS further mediator of fever, PGE2, has been shown to administration did not correlate with the changes in induce hyperalgesia at low doses and hypoalgesia at Tsk. Thus, during the monophasic fever (Fig. 5, left In response to the shockcontradiction between the reports of pain facilitation by inducing and two highest pyrogenic doses, other behav-LPS and several pyrogenic cytokines and the studies iors were also observed: the animals rested their heads showing analgesic activities of the same pyrogens has on the floor of the restrainer, closed their eyes, and quit been resolved. If the nociceptive response is measured chattering.
In association with this behavioral pattern, shortly after pyrogen administration and/or if relathe low AS at late stages of the response to pyrogenic tively low doses of the pyrogen are used, there is a high and hypothermizing doses of LPS is likely to indicate probability of finding hyperalgesia. If, however, nocicepnot simply a restoration of the activity back to the tion is evaluated at later stages of the response and/or normal state, but rather a profound motor inhibition. (6, 10) . It is worth noting that this motor depression could explain why the initial hyperactivity was not reported in some of the papers cited. Indeed, sustained motor inhibition could have masked the preceding shortlasting hyperactivity, especially if activity was averaged over relatively long time periods (as in the majority of studies) or if the motor activity measurement was initiated several hours after pyrogen administration, when the agitation had already ceased (15, 43). The present results suggest that, whereas motor hyperexcitability is an early component of the systemic response to LPS, motor depression is a late component. The same behavioral sequence occurs in various animal species (insects, fishes, poikilothermic mammals, laboratory rodents) in response to several thermal and nontherma1 stressors (23,24).
Early and the Late Phase Syndromes
Definitions.
Our results show that the early phase of a typically biphasic endotoxin fever is characterized by an elevated level of Tb, hyperalgesia, and motor hyperexcitability.
These three symptoms form a relatively stable syndrome, which we term here the early phase syndrome.
The early phase syndrome also includes precise Tb regulation (39) and, possibly, arterial hypertension (30) and an increase in vigilance (28,32).
As discussed above, the response to a pyrogen can be manifested at its late stages with either fever or hypothermia.
The present data show that, in addition to fever or hyperthermia, the late phase is accompanied by low motor activity and hypoalgesia.
It is also known to be associated with low or normal arterial blood pressure (Ref. 30 and our unpublished data) and seems to be coupled with sleepiness (28). Together with sleepiness, the thermoregulatory manifestations of the second febrile phase (threshold dissociation and resultant increased lability of Tb, increased dependence of Tb on T,, and increased probability of hypothermia) have been termed the late phase syndrome (25). Here, we redefine this syndrome by extending its list of symptoms to include hypoalgesia, motor depression, and possibly hypotension.
Phenomenology. Figure 6 shows sickness patterns of animal responses to various doses of LPS. PFS and the subpyrogenic dose of LPS induced no symptoms of either the early or the late phase syndrome.
The low pyrogenic dose of LPS induced a monophasic fever: the early phase syndrome (fever, hyperalgesia, and motor agitation) occurred, but the late phase syndrome did not develop. Higher doses of LPS caused biphasic fever: the early phase syndrome was followed by the late phase syndrome (fever, hypoalgesia, low motor activity). The response to the highest shock-inducing dose was more complex. At the very beginning, the two All data are means; number of animals in a group (in order of the increase in the dose of LPS) is 7,5,5,10,5, or 8. syndromes overlapped, and the motor hyperactivity (a remnant of the early phase symptom) was accompanied by hypothermia and hypoalgesia (rudiments of the late phase symptoms).
Later in the dynamics of the response, hyperactivity disappeared, and the late phase syndrome (hypothermia, hypoalgesia, low motor activity) flourished. Figure 6 clearly demonstrates that, as the dose of LPS increased, both the early and late phase syndromes developed earlier. The first febrile peak occurred at 108 t 11 min in response to 1 ug/kg, 60 t 6 min in response to 10 pg/kg, 45 t 3 min in response to 100 ug/kg, and did not occur at all in response to 1,000 pg/kg. Similarly, in response to LPS doses of 10, 100, and 1,000 pg/kg, the maximal change in Tb associated with the late phase occurred at 165 t 17, 141 t_ 6, and 83 ? 6 min post-LPS, respectively. Threshold dissociation, the major thermoregulatory mechanism of the late febrile phase, has been directly shown to develop already at the very early stages of the response to shock-inducing doses of LPS (27). "Stress hormones," such as corticotropin, also shift the time of the development of threshold dissociation during fever toward its onset (38 Just as the sickness pattern changed with the increase of the LPS dose in the present study, clinical symptoms of sickness change as the severity of the disease increases. A short-lasting, slight infectious challenge (e.g., common intoxication with bacterial exotoxins via food) is usually accompanied by the early phase syndrome only, thus resembling a monophasic fever. In the course of a more serious but still relatively mild infection (e.g., a typical case of influenza), the initial sickness symptoms that correspond to the early phase syndrome are gradually changed to at least some of the symptoms of the late phase syndrome. As the severity of disease further increases, the late phase symptoms become more and more pronounced, thus resembling biphasic fever. With still a further increase in the severity and increasing threat of energy deficiency, the late phase syndrome becomes predominant and endures for a longer time until, finally, it completely overwhelms the early phase syndrome. The latter situation is characteristic of some clinical cases of septic shock and resembles experimental endotoxin shock. As a general rule, the early phase syndrome develops in a previously healthy organism at the onset of its response to an infection. Conversely, the late phase syndrome occurs when the organism is already exhausted (damaged) by the preceding early phase syndrome, weakened by a preexisting pathology, or exposed to an extremely severe, immediately damaging homeostatic challenge.
Perspectives
There are several inconsistencies in the current concept of sickness.
Thus both hyperalgesia (40) (41) (42) (43) and sleep (6, 13) have been recognized as sickness symptoms, although their simultaneous occurrence contradicts common sense. Hart (6) points out another contradiction:
in animals facing a problem of survival with no apparent solution (such as infant separation from mothers), depression is usually accompanied by hypometabolism and hypothermia, but a similar depression in infection is traditionally thought to be associated with fever. Furthermore, the current concept completely ignores hypothermia as a sickness symptom despite the accumulated body of clinical and experimental evidence. Thus clinicians view both fever and hypothermia as symptoms of the systemic inflammatory response syndrome (19), and basic scientists have repeatedly demonstrated that pyrogens possess both hyperthermizing (pyrogenic) and hypothermizing (cryogenic) activities (see, e.g., Refs. 11, 27, 35) . Moreover, the single thermoregulatory mechanism (threshold dissociation), allowing both a rise and fall of Tb, has been shown to develop in response to pyrogens in experimental animals (39) and to occur in patients in response to various insults such as trauma and burns (33). Apparently, in some areas of research (e.g., thermoregulation and pain studies), the symptoms of only the early phase
